Abstract |
279 physicians took part in a multicentre trial to assess the efficacy and acceptability of the combination of 4,4-diphenyl-N-isopropyl-cyclohexylamine-hydrochloride ( pramiverine, Sistalgin) and N-methyl-N-(2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)-aminomethanesulfonate ( metamizole) ( Sistalgin comp) in the forms of ampoules, coated tablets and suppositories. 1301 out of 1329 case reports could be evaluated; in 28 cases treatment was discontinued. The trial included 59% acute colics and 41% subacute recurrent painful spasms of the caval organs. A single presentation form was used in 44%; all other patients were treated with the combined regimen of ampoules/coated tablets/ suppositories. A good or very good result was obtained in 91% of cases, with a low rate of undesired side-effects. In 3%, the result was unsatisfactory. The patients' judgment was in agreement with that of the physician. Both judgments confirmed the rapid onset, long duration and reliable effect of pramiverine/ metamizole in treating colics of the intestinal, biliary and urinary tracts as well as recurrent spastic pain. Similarly favourable results were obtained with all presentation forms.
|
Authors | E Koch, W Eisele |
Journal | Arzneimittel-Forschung
(Arzneimittelforschung)
Vol. 26
Issue 4b
Pg. 745-52
(Apr 1976)
ISSN: 0004-4172 [Print] Germany |
Vernacular Title | Therapieergebnisse mit der Kombination Pramiverin/metamizol in einem Feldversuch |
PMID | 782472
(Publication Type: Clinical Trial, English Abstract, Journal Article)
|
Chemical References |
- Benzhydryl Compounds
- Cyclohexylamines
- Drug Combinations
- Parasympatholytics
- Aminopyrine
- Dipyrone
|
Topics |
- Adolescent
- Adult
- Aged
- Aminopyrine
(analogs & derivatives)
- Benzhydryl Compounds
(adverse effects, therapeutic use)
- Biliary Tract Diseases
(drug therapy)
- Child
- Clinical Trials as Topic
- Colic
(drug therapy)
- Cyclohexylamines
(adverse effects, therapeutic use)
- Dipyrone
(adverse effects, therapeutic use)
- Drug Combinations
- Dysmenorrhea
(drug therapy)
- Female
- Gastrointestinal Diseases
(drug therapy)
- Humans
- Middle Aged
- Parasympatholytics
(adverse effects, therapeutic use)
- Spasm
(drug therapy)
- Urologic Diseases
(drug therapy)
|